Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Seamless Phase IIb/III Clinical Study to Evaluate the Efficacy and Safety of IBI306 in Subjects With Homozygous Familial Hypercholesterolemia in China

NCT04948008 is registered in ClinicalTrials.gov with Shenzhen People's Hospital as lead sponsor.

NCT NCT04948008
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04948008 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Seamless Phase IIb/III Clinical Study to Evaluate the Efficacy and Safety of IBI306 in Subjects With Homozygous Familial Hypercholesterolemia in China
Lead sponsor
Shenzhen People's Hospital
Phase
Phase 2/3
Overall status
Unknown status
Start date
November 5, 2019
Completion date
December 31, 2022
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

familial hypercholesterolemia - homozygous, lipid metabolism disorders, proprotein convertase subtilisin/kexin 9